Trilogy AI Announces Closing of LIFE Financing, Concurrent Private Placements

Core Points - Trilogy AI Corp. has successfully closed a non-brokered private placement financing, raising approximately C$477,866.69 by issuing 6,826,667 common shares at C$0.07 each [1] - The company also completed a concurrent private placement, generating approximately C$362,196.82 from the sale of 5,174,240 common shares at the same price [1] - Additionally, Trilogy AI issued 9,311,500 warrants at C$0.05 each, raising gross proceeds of approximately C$465,575, with each warrant allowing the purchase of one common share for a period of 24 months [1] - The proceeds from these offerings will be utilized for working capital and general corporate purposes [3] Regulatory Information - The common shares from the LIFE Offering are exempt from a hold period under Canadian securities laws, while the private placement shares and warrants are subject to a statutory hold period of 4 months and one day [2] - The securities issued are not registered under the U.S. Securities Act and cannot be offered or sold in the United States without proper registration or exemption [4] Company Overview - Trilogy AI Corp. is focused on transforming the beauty industry through its AI beauty technology known as "Scarlett" [5]